These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 885638)

  • 1. Measurement of fluoride in bone.
    Mernagh JR; Harrison JE; Hancock R; McNeill KG
    Int J Appl Radiat Isot; 1977 Jun; 28(6):581-3. PubMed ID: 885638
    [No Abstract]   [Full Text] [Related]  

  • 2. Applications of the whole-body counter in total-body neutron activation analysis.
    Chamberlain MJ; Fremlin JH; Peters DK; Philip H
    Br J Radiol; 1970 Apr; 43(508):287-8. PubMed ID: 5442507
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutron activation studies and the effect of exercise on osteoporosis.
    Harrison JE
    J Med; 1984; 15(4):285-94. PubMed ID: 6597259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approach to the treatment of bone disease with fluoride.
    Taves DR
    Fed Proc; 1970; 29(3):1185-7. PubMed ID: 4910268
    [No Abstract]   [Full Text] [Related]  

  • 5. Aluminium in bone from patients with renal failure.
    Parsons V; Davies C; Goode C; Ogg C; Siddiqui J
    Br Med J; 1971 Oct; 4(5782):273-5. PubMed ID: 5123910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial-body calcium measurements by in vivo neutron activation analysis: comparisons with x-ray photodensitometry measurements of the radius.
    Harrison JE; McNeill KG; Meema HE; Fenton S; Oreopoulos DG; Sturtridge WC
    J Nucl Med; 1974 Nov; 15(11):929-34. PubMed ID: 4420966
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone fluoride in patients with uremia maintained by chronic hemodialysis.
    Kim D; Del Greco F; Hefferen JJ; Levin NW
    Trans Am Soc Artif Intern Organs; 1970; 16():474-8. PubMed ID: 5454201
    [No Abstract]   [Full Text] [Related]  

  • 8. Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton.
    Harrison JE; McNeill KG; Sturtridge WC; Bayley TA; Murray TM; Williams C; Tam C; Fornasier V
    J Clin Endocrinol Metab; 1981 Apr; 52(4):751-8. PubMed ID: 6970749
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone changes in end-stage oxalosis.
    Brancaccio D; Poggi A; Ciccarelli C; Bellini F; Galmozzi C; Poletti I; Maggiore Q
    AJR Am J Roentgenol; 1981 May; 136(5):935-9. PubMed ID: 6784531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Caniggia A; Vattimo A
    Calcif Tissue Int; 1980; 30(1):5-13. PubMed ID: 6767533
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoride and nutritional osteoporosis: Physicochemical data on bones from an experimental study in dogs.
    Henrikson PA; Lutwak L; Krook L; Skogerboe R; Kallfelz F; Bélanger LF; Marier JR; Sheffy BE; Romanus B; Hirsch C
    J Nutr; 1970 Jun; 100(6):631-42. PubMed ID: 5453360
    [No Abstract]   [Full Text] [Related]  

  • 12. [New viewpoints on the physiology and toxocology of fluorides].
    Hagen AR
    Nor Tannlaegeforen Tid; 1967 Oct; 77(8):469-86. PubMed ID: 5235269
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoride treatment of bone rarefaction in multiple myeloma and osteoporosis. A review.
    Cohen P; Nichols GL; Banks HH
    Clin Orthop Relat Res; 1969; 64():221-49. PubMed ID: 4893445
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone metabolism and its assessment in renal failure.
    Coen G; Mazzaferro S
    Nephron; 1994; 67(4):383-401. PubMed ID: 7969670
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of fluoride on bone in chronic renal failure.
    Lough J; Noonan R; Gagnon R; Kaye M
    Arch Pathol; 1975 Sep; 99(9):484-7. PubMed ID: 1164250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutron activation analysis of a hand-a method of monitoring progressive bone disease.
    McIntosh JA; Catto GR
    Biomed Eng; 1974 Jun; 9(6):254-6 passim. PubMed ID: 4837582
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of fluoride alone or fluoride followed by calcium and vitamin D on disuse osteoporosis of the rat tail vertebrae.
    Rosen D; Gedalia I; Anaise J; Simkin A; Arcan M
    Calcif Tissue Res; 1975 Nov; 19(1):9-15. PubMed ID: 1081426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal renewal and metabolic bone disease.
    Harris WH; Heaney RP
    N Engl J Med; 1969 Feb; 280(6):303-11 concl. PubMed ID: 4302928
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical investigation in metabolic bone disease. Quantitative measurements of bone mineral.
    Evens RG; Pak CY; Ashburn W; Bartter FC
    Invest Radiol; 1969; 4(6):364-9. PubMed ID: 5368348
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium fluoride in the treatment of osteoporosis.
    Williams CC
    Clin Invest Med; 1982; 5(2-3):195-7. PubMed ID: 6981483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.